{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:12:33Z","timestamp":1789625553560,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.bone.2018.05.021","type":"journal-article","created":{"date-parts":[[2018,5,19]],"date-time":"2018-05-19T02:14:36Z","timestamp":1526696076000},"page":"137-143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["A comparative study of quality of life, functional and bone outcomes in osteogenesis imperfecta with bisphosphonate therapy initiated in childhood or adulthood"],"prefix":"10.1016","volume":"113","author":[{"given":"Andrew G.","family":"Feehan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret R.","family":"Zacharin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelina S.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Simm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9418","key":"10.1016\/j.bone.2018.05.021_bb0005","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0140-6736(04)16051-0","article-title":"Osteogenesis imperfecta","volume":"363","author":"Rauch","year":"2004","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.bone.2018.05.021_bb0010","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11914-007-0023-z","article-title":"Osteogenesis imperfecta: epidemiology and pathophysiology","volume":"5","author":"Martin","year":"2007","journal-title":"Curr. Osteoporos. Rep."},{"issue":"1","key":"10.1016\/j.bone.2018.05.021_bb0015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1469-8749.2008.03222.x","article-title":"Effects of bisphosphonates in children with osteogenesis imperfecta: an AACPDM systematic review","volume":"51","author":"Castillo","year":"2009","journal-title":"Dev. Med. Child Neurol."},{"issue":"10028","key":"10.1016\/j.bone.2018.05.021_bb0020","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/S0140-6736(15)00728-X","article-title":"Osteogenesis imperfecta","volume":"387","author":"Forlino","year":"2016","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bone.2018.05.021_bb0025","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2106\/00004623-198062010-00017","article-title":"Aftermath of osteogenesis imperfecta: the disease in adulthood","volume":"62","author":"Moorefield","year":"1980","journal-title":"J. Bone Joint Surg. Am."},{"issue":"1","key":"10.1016\/j.bone.2018.05.021_bb0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s002640100292","article-title":"Quality of life in osteogenesis imperfecta","volume":"26","author":"Widmann","year":"2002","journal-title":"Int. Orthop."},{"issue":"5","key":"10.1016\/j.bone.2018.05.021_bb0035","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.apmr.2003.08.085","article-title":"Osteogenesis imperfecta in childhood: impairment and disability. A prospective study with 4-year follow-up","volume":"85","author":"Engelbert","year":"2004","journal-title":"Arch. Phys. Med. Rehabil."},{"issue":"8","key":"10.1016\/j.bone.2018.05.021_bb0040","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1136\/jcp.49.8.627","article-title":"Causes of death in osteogenesis imperfecta","volume":"49","author":"McAllion","year":"1996","journal-title":"J. Clin. Pathol."},{"issue":"2","key":"10.1016\/j.bone.2018.05.021_bb0045","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1210\/jc.2008-1531","article-title":"Clinical review: bisphosphonate use in childhood osteoporosis","volume":"94","author":"Bachrach","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2018.05.021_bb0050","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005088.pub2","article-title":"Bisphosphonate therapy for osteogenesis imperfecta","volume":"4","author":"Phillipi","year":"2008","journal-title":"Cochrane Database Syst. Rev."},{"issue":"9","key":"10.1016\/j.bone.2018.05.021_bb0055","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa011807","article-title":"Intravenous zoledronic acid in postmenopausal women with low bone mineral density","volume":"346","author":"Reid","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.bone.2018.05.021_bb0060","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.apmr.2015.06.006","article-title":"Multidisciplinary treatment of severe osteogenesis imperfecta: functional outcomes at skeletal maturity","volume":"96","author":"Montpetit","year":"2015","journal-title":"Arch. Phys. Med. Rehabil."},{"issue":"11","key":"10.1016\/j.bone.2018.05.021_bb0065","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1515\/JPEM.2004.17.11.1511","article-title":"Pamidronate treatment of less severe forms of osteogenesis imperfecta in children","volume":"17","author":"Zacharin","year":"2004","journal-title":"J. Pediatr. Endocrinol."},{"issue":"3","key":"10.1016\/j.bone.2018.05.021_bb0070","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2106\/JBJS.L.01596","article-title":"Behavior of scoliosis during growth in children with osteogenesis imperfecta","volume":"96","author":"Anissipour","year":"2014","journal-title":"J. Bone Joint Surg."},{"key":"10.1016\/j.bone.2018.05.021_bb0075","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bone.2016.02.018","article-title":"Scoliosis in osteogenesis imperfecta caused by COL1A1\/COL1A2 mutations - genotype-phenotype correlations and effect of bisphosphonate treatment","volume":"86","author":"Sato","year":"2016","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.bone.2018.05.021_bb0080","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/pri.1546","article-title":"Functioning and quality of life in adults with mild-to-moderate osteogenesis imperfecta","volume":"18","author":"Balkefors","year":"2013","journal-title":"Physiother. Res. Int."},{"issue":"1","key":"10.1016\/j.bone.2018.05.021_bb0085","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/ajmg.a.37377","article-title":"Quality of life in osteogenesis imperfecta: a mixed-methods systematic review","volume":"170A","author":"Dahan-Oliel","year":"2016","journal-title":"Am. J. Med. Genet. A"},{"issue":"6","key":"10.1016\/j.bone.2018.05.021_bb0090","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1002\/ajmg.a.36545","article-title":"Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment","volume":"164","author":"Van Dijk","year":"2014","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.bone.2018.05.021_bb0095","series-title":"WHOQOL-BREF: Introduction, Administration, Scoring and Generic Version of the Assessment: Field Trial Version, December 1996","author":"Organization WH","year":"1996"},{"issue":"2","key":"10.1016\/j.bone.2018.05.021_bb0100","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000430863","article-title":"Adult quality of life and psychosocial outcomes of childhood onset hypopituitarism","volume":"84","author":"Kao","year":"2015","journal-title":"Horm. Res. Paediatr."},{"issue":"8","key":"10.1016\/j.bone.2018.05.021_bb0105","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1249\/01.MSS.0000078924.61453.FB","article-title":"International physical activity questionnaire: 12-country reliability and validity","volume":"35","author":"Craig","year":"2003","journal-title":"Med. Sci. Sports Exerc."},{"key":"10.1016\/j.bone.2018.05.021_bb0110","series-title":"Guidelines for Data Processing and Analysis of the International Physical Activity Questionnaire (IPAQ)\u2013Short and Long Forms","author":"Committee","year":"2005"},{"issue":"1","key":"10.1016\/j.bone.2018.05.021_bb0115","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1479-5868-6-21","article-title":"The international prevalence study on physical activity: results from 20 countries","volume":"6","author":"Bauman","year":"2009","journal-title":"Int. J. Behav. Nutr. Phys. Act."},{"issue":"6","key":"10.1016\/j.bone.2018.05.021_bb0120","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med. Care"},{"issue":"2","key":"10.1016\/j.bone.2018.05.021_bb0125","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J. Biomed. Inform."},{"key":"10.1016\/j.bone.2018.05.021_bb0135","author":"National Health Survey"},{"key":"10.1016\/j.bone.2018.05.021_bb0140","article-title":"Bisphosphonate therapy for osteogenesis imperfecta","volume":"10","author":"Dwan","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"issue":"6","key":"10.1016\/j.bone.2018.05.021_bb0145","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1359\/JBMR.050109","article-title":"Controlled trial of pamidronate in children with types III and IV osteogenesis imperfecta confirms vertebral gains but not short-term functional improvement","volume":"20","author":"Letocha","year":"2005","journal-title":"J. Bone Miner. Res."},{"issue":"5","key":"10.1016\/j.bone.2018.05.021_bb0150","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1359\/JBMR.041232","article-title":"Intravenous neridronate in children with osteogenesis imperfecta: a randomized controlled study","volume":"20","author":"Gatti","year":"2005","journal-title":"J. Bone Miner. Res."},{"issue":"9902","key":"10.1016\/j.bone.2018.05.021_bb0155","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/S0140-6736(13)61091-0","article-title":"Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebo-controlled trial","volume":"382","author":"Bishop","year":"2013","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.bone.2018.05.021_bb0160","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1097\/01.bpo.0000176162.78980.ed","article-title":"Impact of alendronate on quality of life in children with osteogenesis imperfecta","volume":"25","author":"Seikaly","year":"2005","journal-title":"J. Pediatr. Orthop."},{"issue":"2","key":"10.1016\/j.bone.2018.05.021_bb0165","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1210\/jc.2010-0636","article-title":"Alendronate for the treatment of pediatric osteogenesis imperfecta: a randomized placebo-controlled study","volume":"96","author":"Ward","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.bone.2018.05.021_bb0170","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1359\/jbmr.090213","article-title":"Risedronate in the treatment of mild pediatric osteogenesis imperfecta: a randomized placebo-controlled study","volume":"24","author":"Rauch","year":"2009","journal-title":"J. Bone Miner. Res."},{"issue":"4","key":"10.1016\/j.bone.2018.05.021_bb0175","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.bone.2006.11.020","article-title":"Long-bone changes after pamidronate discontinuation in children and adolescents with osteogenesis imperfecta","volume":"40","author":"Rauch","year":"2007","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.bone.2018.05.021_bb0180","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000369582","article-title":"The long-term effects of switching from active intravenous bisphosphonate treatment to low-dose maintenance therapy in children with osteogenesis imperfecta","volume":"83","author":"Biggin","year":"2015","journal-title":"Horm. Res. Paediatr."},{"issue":"5","key":"10.1016\/j.bone.2018.05.021_bb0185","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s001980170112","article-title":"The burden of osteoporotic fractures: a method for setting intervention thresholds","volume":"12","author":"Kanis","year":"2001","journal-title":"Osteoporos. Int."},{"issue":"16","key":"10.1016\/j.bone.2018.05.021_bb0190","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1097\/00007632-199908150-00008","article-title":"Spinal deformity, pulmonary compromise, and quality of life in osteogenesis imperfecta","volume":"24","author":"Widmann","year":"1999","journal-title":"Spine"},{"issue":"9419","key":"10.1016\/j.bone.2018.05.021_bb0195","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(04)16101-1","article-title":"Skeletal effects and functional outcome with olpadronate in children with osteogenesis imperfecta: a 2-year randomised placebo-controlled study","volume":"363","author":"Sakkers","year":"2004","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.bone.2018.05.021_bb0200","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jpeds.2005.10.041","article-title":"Effect of intravenous pamidronate therapy on functional abilities and level of ambulation in children with osteogenesis imperfecta","volume":"148","author":"Land","year":"2006","journal-title":"J. Pediatr."},{"issue":"7","key":"10.1016\/j.bone.2018.05.021_bb0205","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3109\/09638280903204690","article-title":"A population-based study of demographical variables and ability to perform activities of daily living in adults with osteogenesis imperfecta","volume":"32","author":"Wekre","year":"2010","journal-title":"Disabil. Rehabil."},{"issue":"7","key":"10.1016\/j.bone.2018.05.021_bb0210","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1080\/00048670902970882","article-title":"2007 National Survey of mental health and wellbeing: methods and key findings","volume":"43","author":"Slade","year":"2009","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.bone.2018.05.021_bb0215","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s13023-015-0362-2","article-title":"Initial report of the osteogenesis imperfecta adult natural history initiative","volume":"10","author":"Tosi","year":"2015","journal-title":"Orphanet J. Rare Dis."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328218302114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328218302114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T16:32:37Z","timestamp":1560789157000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328218302114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":42,"alternative-id":["S8756328218302114"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2018.05.021","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comparative study of quality of life, functional and bone outcomes in osteogenesis imperfecta with bisphosphonate therapy initiated in childhood or adulthood","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2018.05.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}